Tải bản đầy đủ (.pdf) (39 trang)

Hiệu quả của chương trình quản lý kháng sinh trong việc kiểm soát sử dụng kháng sinh tại khoa Hồi sức tích cực và dự phòng trong phẫu thuật

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (1.46 MB, 39 trang )

<span class='text_page_counter'>(1)</span><div class='page_container' data-page=1>

<b>The Antimicrobial Stewardship </b>


<b>Program at the ICU and Surgical </b>


<b>antibiotic prophylaxis at Cho Ray </b>



<b>hospital </b>



<b>Pham Thi Ngoc Thao MD, PhD</b>


</div>
<span class='text_page_counter'>(2)</span><div class='page_container' data-page=2>

<b>CONTENT </b>



• Hospital acquired infection at ICU and surgical site
infection condition


• The Antimicrobial stewardship Program (AMS) at
Cho Ray hospital


• The initial results at the ICU and Surgical prophylaxis
• Future plan


</div>
<span class='text_page_counter'>(3)</span><div class='page_container' data-page=3>

<b>ICU PATIENTS ARE AT RISK</b>



• About 30% of ICU patients in
developing countries have at
least one hospital acquired
infection (HAI) (1)


• In USA, there was 417.946
(24,6%) ICU patients had HAI
by CDC (2)


• (1) WHO (2006), medical errors: The global big isse


/>


</div>
<span class='text_page_counter'>(4)</span><div class='page_container' data-page=4>

<b>ICU PATIENTS ARE AT RISK</b>



• The ICU patients have 2-5 folds of risk of infection
comparing to the others(1).


• The HAI was 2-3 folds in developing countries(2).


• In Vietnam, a research done in 2012 showed that
VAP was 39.4% at Cho Ray hospital and 51.6% at
103 Military hospital(3), (4)


(1), Ewans TM, Ortiz CR, LaForce FM. Prevention and control of nosocomial infection in the intensive care unit.


In: Irwin RS, Cerra FB, Rippe JM, editors. Intensive Care Medicine. 4th ed. New York: Lippincot-Ravan; 1999. pp. 1074–80.
(2) WHO (2006), medical errors: The global big isse />


(3)Lê Thị Anh Thư. “Nhiễm khuẩn bệnh viện trên các bệnh nhân thở máy”


</div>
<span class='text_page_counter'>(5)</span><div class='page_container' data-page=5>

<b>THE COST FOR HAI </b>



• The cost for HAI in Argentina (1):


- For CLABSI was 4.888 USD/case
- HAP: 2.255 USD /case.


• In Vietnam (1):


- HAI was about 30 - 40%


- The hospital length of stay was 10-15 days longer.


- The cost was increased 2.9 million VND/case


(*) Francisco Higuera, et al (2015). “Attributable Cost and Length of Stay for Patients With Central Venous Catheter–Associated Bloodstream Infection in Mexico City
Intensive Care Units: A Prospective, Matched Analysis”


</div>
<span class='text_page_counter'>(6)</span><div class='page_container' data-page=6>

<b>SURGICAL SITE INFECTION = SSI</b>



• The infection in <i>≤ 30 days of surgery or within a </i>
<i>year in the case of implants</i>


</div>
<span class='text_page_counter'>(7)</span><div class='page_container' data-page=7>

Jarvis, Infection Control Hospital Epidemiology 1996;17


<b>SURGICAL SITE INFECTION </b>



• Covers about 14 -16% of HAI
• In about 2-5% operations


• There are about 40 Million operations per year in
USA.


• There are about 42.000 operations per year at
Cho Ray hopstal.


• SSI increased hospital length of stay about 7.5
days .


• The cost was increased about 2.700 – 36.000
USD/ case


• The medical cost increased 130 - 845 Million USD


per year in USA.


</div>
<span class='text_page_counter'>(8)</span><div class='page_container' data-page=8>

<b>Case Control* Study of 255 Pairs</b>


infection Non -infection


Readmission 41% 7%


Cost 7.531 Usd 3.844 USD


 LOS 11 days 6 days


ICU admission 29% 18%


Mortality 7.8% 3.5%


</div>
<span class='text_page_counter'>(9)</span><div class='page_container' data-page=9>

<b>RISK FACTORS </b>



• Age


• Obesity
• DM


• Malnutrition


• Long operation
• Distal infection


• Corticosteroides



• Surgical site hygiene
• Procedure


• Technique
• Drainage


• Inappropriate Antibiotic Prophylaxis
• Smoking


</div>
<span class='text_page_counter'>(10)</span><div class='page_container' data-page=10>

<b>THE CARE BUNDLE FOR SSI </b>



1. Prophylactic antibiotic given within one hour prior
to surgical incision


2. Appropriate prophylactic antibiotic selection for
surgical patients


3. Prophylactic antibiotics discontinued within 24
hours after surgery end time (48 hours for cardiac
surgery)


</div>
<span class='text_page_counter'>(11)</span><div class='page_container' data-page=11>

<b>THE CARE BUNDLE FOR SSI </b>



5. Surgery patients with appropriate hair removal


6. Surgery Patients with Perioperative Temperature
Management – maintaining normothermia


7. Urinary Catheter removal on postoperative Day 1
or 2 with day of surgery being day zero.



</div>
<span class='text_page_counter'>(12)</span><div class='page_container' data-page=12>

<i>Safe Surgery Saves Lives</i>


</div>
<span class='text_page_counter'>(13)</span><div class='page_container' data-page=13>

<b>APPLICATION OF SURGICAL SAFETY CHECKLIST </b>


<b>Variables </b> <b>Baseline</b> <b>Checklist</b> <b>P</b>


Number of patients 3733 3955
-Mortality 1.5% 0.8% 0.003
Complications 11.0% 7.0% <0.001


SSI 6.2% 3.4% <0.001


Re-operation 2.4% 1.8% 0.047


Haynes et al (2009) A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population. <i>New England Journal of Medicine</i>


360:491-9.


</div>
<span class='text_page_counter'>(14)</span><div class='page_container' data-page=14>

<b>BALANCE THE RISK AND BENEFIT </b>


Early, appropriate use to
improve patients’ outcome


Inappropriate use
increased risk, cost and


side effect

<b>ANTIBIOTIC USE </b>




</div>
<span class='text_page_counter'>(15)</span><div class='page_container' data-page=15>

-

<b>THE 30 PRINCIPLE IN AMS </b>



- 30% inpatients were indicated
antibiotics


- 30% inappropriate antibiotic usage
- 30% Inappropriate antibiotic


surgical prophylaxis .


- 30% cost for antibiotic use .
- AMS reduced 10-30% cost




</div>
<span class='text_page_counter'>(16)</span><div class='page_container' data-page=16>

<b>AMS GOALS</b>



• Appropriate, safe antibiotic use
• Reduce LOS


• Reduce the cost


</div>
<span class='text_page_counter'>(17)</span><div class='page_container' data-page=17>

<b>AMS JOURNEY AT CHO RAY HOSPITAL</b>


<b>2009</b>
<b>2010</b>
<b>2013</b>
<b>2015</b>
<b>2016</b>
<b>2017</b>
<b>2020</b>

<b>Data </b>
<b>collection</b>
<b>1st </b>
<b>Guideline </b>
<b>2nd </b>
<b>Guideline </b>
<b>Pilot AMS </b>


• <b>All of </b>


<b>departments</b>


• <b>3rd </b>


</div>
<span class='text_page_counter'>(18)</span><div class='page_container' data-page=18>

<b>AMS DONE AT THE ICU, CHO RAY HOSPITAL</b>


• Patients stratification


• The guideline compliance survey.
• HAI monitoring


• Antimicrobial resistance survey


</div>
<span class='text_page_counter'>(19)</span><div class='page_container' data-page=19>

<b>COMPLIANCE </b>


95,5
96
96,5
97
97,5
98

98,5
99
99,5
100
100
97,2


Sample referral prior
Antibiotics use (%)


Guideline compliance


</div>
<span class='text_page_counter'>(20)</span><div class='page_container' data-page=20>

<b>PREVALENCE OF VAP/1000 </b>


<b>VENTILATED –DAY</b>



<b>MONTH</b>


<b>34,78</b>
<b>39,58</b>


<b>35,84</b>
<b>35,53</b>


<b>38,16</b>


<b>36,84</b>


<b>24,61</b>


<b>21,38</b>


<b>32,01</b>


<b>26,97</b>


<b>30,20</b>


</div>
<span class='text_page_counter'>(21)</span><div class='page_container' data-page=21>

<b>PREVALENCE OF CLABSI/1000 VENOUS- DAY</b>



<b>3,27</b>


<b>5,12</b>


<b>2,22</b>


<b>3,48</b>


<b>7,35</b>


<b>3,33</b>


<b>0,00</b>


<b>2,15</b>


<b>1,10</b>


<b>6,90</b>


<b>2,13</b>



<b>1</b> <b>2</b> <b>3</b> <b>4</b> <b>5</b> <b>6</b> <b>7</b> <b>8</b> <b>9</b> <b>10</b> <b>11</b> <b>12</b>


</div>
<span class='text_page_counter'>(22)</span><div class='page_container' data-page=22>

<b>PREVALENCE OF UTI/1000</b>


<b>SONDE –DAY </b>



<b>3,17</b>


<b>1,28</b>


<b>3,38</b>


<b>4,53</b>


<b>2,21</b>


<b>0,00</b>


<b>6,45</b>


<b>1,10</b>


<b>1,14</b> <b>1,06</b>


<b>1.11</b>


<b>1</b> <b>2</b> <b>3</b> <b>4</b> <b>5</b> <b>6</b> <b>7</b> <b>8</b> <b>9</b> <b>10</b> <b>11</b> <b>12</b>


</div>
<span class='text_page_counter'>(23)</span><div class='page_container' data-page=23>

<b>THE DISTRIBUTION OF MULTIDRUG </b>


<b>RESISTANT BACTERIA </b>




57,7


46,2 53,2 53,5 58,3


0


100 100


50
25,1 <sub>39,4</sub> 33,5 <sub>28,3</sub> 27,3


100


0 0


0
17,2 14,2 13,3 18,2 14,5


0 0 0


50


</div>
<span class='text_page_counter'>(24)</span><div class='page_container' data-page=24>

<b>CLINICAL RESULTS </b>



86.7% well-respone (n=811)


Hết nhiễm
khuẩn
Giảm TT
nhiễm khuẩn


TT nhiễm
khuẩn không
thuyên giảm


Đang điều trị
chưa đánh
giá
59,8
26,9
12,1
1,2


<b>Well Response Decreased </b>
<b>infection </b>


<b>Not </b>
<b>Response</b>


</div>
<span class='text_page_counter'>(25)</span><div class='page_container' data-page=25>

<b>AMS IN SURGICAL PROPHYLAXIS </b>



• Our guidelines in 2010, 2013 and 2016
• Training courses


• Hospital regulations in SSI classification, Antibiotic
prophylasix .


• Antibiotic surgical prophylasix should be done
before referring patients to OR .


• Randomised audit



• Review and feedback


</div>
<span class='text_page_counter'>(26)</span><div class='page_container' data-page=26>

<b>A STUDY IN 2016 </b>



• Cross sectional study : 301 clean, clean


contanminated cases in 2015 retrospectively
• 311 clean, clean contanminated cases in 2016


prospectively
• The outcomes


- Guideline compliance rate
- Surface SSI


</div>
<span class='text_page_counter'>(27)</span><div class='page_container' data-page=27>

27


<b>THE GUIDELINE COMPLIANCE RATE INCREASED</b>


<i>There was significant difference in appropriate dose for</i>
<i>surgiacal prophylaxis in 2015 and 2016 (p = 0.0028)</i>


Dose 2015 2016


n Incidence (%) n Incidence %


Appropriate <sub>168</sub> <b><sub>58.7</sub></b> <sub>214</sub> <b><sub>68.8</sub></b>


Inappropriate <sub>118</sub> <sub>41.3</sub> <sub>79</sub> <sub>25.4</sub>



</div>
<span class='text_page_counter'>(28)</span><div class='page_container' data-page=28>

<i>There was associated bettwen inappropriate dose and SSI </i>


<i>(</i>p <0,05)


Dose


<b>Incidence of SSI in 2015 </b> <b>Incidence of SSI in 2016 </b>


Yes No Yes No


<b>Appr</b> <b>9 (5.3%)</b> 160 (94.7%) <b>4 (1.9%)</b> 210 (98.1%)


Inappr 8 (6.8%) 110 (93.2%) 9 (11.4%) 70 (88.6%)
Total <b>17 (5.9%)</b> 270 (94.1%) <b>13 (4.4%)</b> 280 (95.6%)


</div>
<span class='text_page_counter'>(29)</span><div class='page_container' data-page=29>

<b>THE GUIDELINE COMPLIANCE </b>


<b>IN 2015 AND 2016 </b>



<b>P = 0.0028</b>


</div>
<span class='text_page_counter'>(30)</span><div class='page_container' data-page=30>

<b>THE SSI </b>



</div>
<span class='text_page_counter'>(31)</span><div class='page_container' data-page=31>

<b>Year</b> <b>2015</b> <b>2016</b>
<b>Variables</b> N Incidenc


e (%)


N Incidence
(%)



<b>Appr</b> <sub>33</sub> <b><sub>14.0</sub></b> <sub>128</sub> <b><sub>62,4</sub></b>


<b>Inappr</b>


202 86.0 77 37,6


<b>Total</b> <sub>235</sub> <sub>100.0</sub> <sub>205</sub> <sub>100.0</sub>


Reduced inappropriate in 48.4 % patients


Redued <b>30.000 - 50.000 days of antibiotic treatment</b>


<b>THE COST </b>



</div>
<span class='text_page_counter'>(32)</span><div class='page_container' data-page=32>

<b>THE GUIDELINE COMPLIANCE IN </b>


<b>2017 BY MONTHLY</b>



<b>71,9</b>


<b>35</b>


<b>73,8</b> <b><sub>73,1</sub></b>


<b>59,8</b>


<b>90,4</b>


<b>73,2</b>
<b>83,3</b>



<b>77,2</b> <b>80,7</b>


<b>90,4</b>


<b>80,6</b>


</div>
<span class='text_page_counter'>(33)</span><div class='page_container' data-page=33>

<b>THE GUIDELINE COMPLIANCE FOR SURGICAL </b>


<b>PROPHYLAXIS FROM 2015 TO 2017</b>



<b>14</b>


<b>62,4</b>


<b>76,6</b>


Năm 2015 Năm 2016 Năm 2017


</div>
<span class='text_page_counter'>(34)</span><div class='page_container' data-page=34>

<b>21,3%</b>


<b>20,4%</b>


<b>18,5%</b>


<b>17,2%</b> <b>17,05%</b>


<b>2013</b> <b>2014</b> <b><sub>USD</sub>2 M </b> <b>2015</b> <b>2016</b> <b>2017</b>


<b>1 M </b>



<b>USD </b> <b>200.000 </b>
<b>USD</b>


</div>
<span class='text_page_counter'>(35)</span><div class='page_container' data-page=35>

<b>Hospital acquired infection </b>


<b>HAI AND THE 5 MOST COMMON MDR </b>


<b>BACTERIA </b>



</div>
<span class='text_page_counter'>(36)</span><div class='page_container' data-page=36>

<b>FUTURE PLAN </b>



• AMS will be done in all clinical departments


</div>
<span class='text_page_counter'>(37)</span><div class='page_container' data-page=37>

<b>LESSONS LEARNT </b>



• The leadership
• Teamwork


• Encourage and commendation
• Short term and long term goals
• Use EBM with local data


</div>
<span class='text_page_counter'>(38)</span><div class='page_container' data-page=38>

<b>CONCLUSIONS</b>



• The AMS at Cho Ray hospital has a good initial
results at the ICU and Surgical prophylaxis.


• The guideline compliance increased and the DDD
reduced annually.


• The HAI was reduced.



• The MDR bacteria was well controlled.


</div>
<span class='text_page_counter'>(39)</span><div class='page_container' data-page=39></div>

<!--links-->
Một số kiến nghị nhằm nâng cao hiệu quả của công tác quản lý nguyên vật liệu ở công ty xây dựng điện và dịch vụ phát triển nông thôn
  • 63
  • 703
  • 1
  • ×